404: Page not Found

To find an doctor profile, first select a location from the home page and then search.

If you can't find the page you're looking for using the navigation above, please Contact Us.

 
The Selection Process

In making selections for Super Doctors, MSP Communications employs a rigorous multi-step process designed to identify healthcare providers who have attained a high degree of peer recognition and professional achievement. Super Doctors is a selective yet diverse listing of outstanding doctors, representing consumer-oriented medical specialties.

Read more…


Americans’ heart health varies significantly from state to state

"Americans reported having on average more than four of the seven risk factors for heart disease. We also found large disparities by age, sex, race/ethnicity and levels of education,"said Jing Fang, M.D., M.S., an epidemiologist with the CDC's Division for Heart Disease and Stroke Prevention in Atlanta, Ga.

Read more.

American Heart Association Survey Reveals Americans Have Potentially Dangerous Misconceptions About Heart Failure

Nearly six million Americans currently live with heart failure, yet a recent national survey found potentially dangerous misconceptions and knowledge gaps about the disease.

Read more.

“Off-the-shelf” artificial blood vessels may reduce dialysis complications

Scientists bioengineered an artificial blood vessel by seeding human aorta cells onto a biodegradable mesh tube. In the process, a tubular vein develops in two months as the growing cells secrete proteins and the mesh support structure dissolves. "Off-the-shelf" blood vessels could one day reduce some complications of dialysis treatment...

Read more.

FDA Approves Cell Therapy for Patients with Blood Cancers to Reduce Risk of Infection Following Stem Cell Transplantation

Today, the U.S. Food and Drug Administration approved Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection. The product is intended for use in adults and pediatric patients 12 years and older with blood cancers planned for umbilical cord blood transplantation following a myeloablative conditioning regimen (treatment such as radiation or chemotherapy). 

Read more.

What is Super Doctors?
Super Doctors Magazine

Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications. Please note: Doctors cannot pay to be included on Super Doctors® listings nor are they paid to provide input.

Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.

Click here for more details



Browse Super Doctors
Browse Medical Specialties

More ...

Browse
Locations

More ...